RMD Congressional Stock Trades & Insider Buying (2026)

RMD insider buying and selling over the past year

Insiders at RESMED INC only sold stock in the open market over the past year: 20 Form 4 sales totaling $12.07M, against no open-market purchases.

Most of the selling was pre-scheduled: 20 of the 20 sales (100.0%) were flagged as Rule 10b5-1 plan trades, which are set up in advance and say less about an insider's current view than discretionary sales. Activity clustered in 2025-11 (5 trades) and 2025-12 (4 trades); the latest filing in this window is dated 2026-03-09. The average open-market sale price was $253.13; the last close of $238.97 is 5.6% below that level, so sellers exited above the current price. The single largest trade was a sale of 8,011 shares worth $2.00M on 2025-11-07. Since the most recent filing the stock has moved -5.5%, from $252.93.

Where RMD trades relative to its one-year range

RESMED INC closed at $238.97 on 2026-10-16, inside a one-year range of $182.82 to $275.96. That puts the stock in the middle of its range, at 60.3% of the distance from low to high. Over one year the share price moved -11.5%, and over roughly three months +20.1%. Average daily volume over the last month was about 1,197,600 shares.

Across 83 companies in the same SEC industry group (SIC 38) with a full year of prices in Gemral Edge, the median one-year return was +13.2%. RMD is behind that median and beat 22% of that peer group on this measure.

Members of Congress who traded RMD

STOCK Act disclosures show 30 trades in RMD by 5 members of Congress over five years (14 purchases, 16 sales), most recently on 2026-09-11. The most active traders were Ro Khanna (D-CA), 18 trades; Kelly Morrison (D-MN), 5 trades; Tommy Tuberville (R-AL), 5 trades; Alan Armstrong (R-OK), 1 trade; Robert P. Bresnahan, Jr. (R-PA), 1 trade.

By party the trades split 23 by Democrats, 7 by Republicans; by chamber, 24 from the House, 6 from the Senate.

RMD lobbying disclosures

RESMED INC appears in 2 Lobbying Disclosure Act filings between 2018 and 2018, with $80.0K in reported lobbying spend.

Compare RMD with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to RMD:

• LHX one-year return -12.6%
• NOC one-year return -13.2%
• STE one-year return -7.3%
• GEHC one-year return -5.2%
• ZBH one-year return -4.9%

Sources and method

Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-03-09
• edge_prices_eod (end-of-day close) — as of 2026-10-16
• House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2026-09-11
• Senate LDA filings (edge_lobbying_filings)

RMD data questions

Are RMD insiders buying or selling stock?

Insiders at RESMED INC only sold stock in the open market over the past year: 20 Form 4 sales totaling $12.07M, against no open-market purchases.

What is the one-year price range for RMD?

Based on end-of-day closes through 2026-10-16, RMD traded between $182.82 and $275.96, last closing at $238.97.

Has any member of Congress traded RMD stock?

Yes. 5 members disclosed 30 trades in RMD over five years; the most recent disclosed trade date is 2026-09-11.